As of 10:32 AM on the 1st, Samsung Biologics is trading at 773,000 KRW, down 0.26% from the previous day. This represents a 23.48% increase compared to June 3. Samsung Biologics is known as the holding company for Samsung Group's bio business.
Today, foreigners are tentatively recorded as net buyers of 1,207 shares. Over the past five days, individual investors have net bought 47,785 shares, while foreigners and institutions have net sold 58,612 shares and 2,755 shares, respectively.
On June 24, Samsung Biologics was a market topic for its "strong performance on a 380 billion KRW contract signing."

[Table] Foreigners and Institutions Net Trading Volume (Unit: shares)

※ This article was generated in real-time by an article automation algorithm jointly developed by Asia Economy and the financial AI specialist company Thinkpool.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
![Clutching a Stolen Dior Bag, Saying "I Hate Being Poor but Real"... The Grotesque Con of a "Human Knockoff" [Slate]](https://cwcontent.asiae.co.kr/asiaresize/183/2026021902243444107_1771435474.jpg)
